Type 2 Diabetes: Integrative Care for Blood Sugar, Insulin Resistance and Diet

What drives type 2 diabetes? Insulin resistance, abdominal fat and nutrient deficiencies

Type 2 diabetes develops when muscle, fat and liver cells respond poorly to insulin and the pancreas cannot make enough extra insulin to compensate, according to NIDDK [1]; excess weight, a large waist and family history raise the risk.

• Abdominal fat in India: 39.5% of adults in the ICMR-INDIAB study had abdominal obesity and 28.6% general obesity [2]; a WHO expert consultation found that Asian populations have higher diabetes risk at lower body mass index than European populations [5].
• Deficiencies: metformin can lower vitamin B12 levels, according to the US National Institutes of Health [3][6]. Blood tests do not show how much magnesium the body holds [7], so we judge magnesium from diet, symptoms and history.
• Magnesium in the diet: in a 2020 meta-analysis of 41 studies, people with the highest magnesium intake had a 22% lower risk of type 2 diabetes than those with the lowest [8]; this is an association, not proof of cause.
• Vitamin D: in the D2d trial of 2,423 adults with prediabetes, vitamin D3 did not significantly lower the risk of diabetes over 2.5 years [9]; a 2023 analysis that pooled three trials found a 15% lower risk, an absolute reduction of 3.3% over 3 years [10]. The evidence is mixed.
• Metformin and B12: in a 2019 meta-analysis of 31 studies, people taking metformin had about twice the risk of vitamin B12 deficiency, depending on dose and duration [6].
• What this means for you: test insulin resistance, vitamin D and B12 alongside blood glucose, and correct what is low under supervision rather than on your own.

What is type 2 diabetes?

Type 2 diabetes is the most common form of diabetes: blood glucose rises because the pancreas does not produce enough insulin and the body has trouble using it, according to NIDDK [1].

• Worldwide: the number of people living with diabetes rose from 200 million in 1990 to 830 million in 2022, according to the World Health Organization [11].
• In India: 11.4% of adults have diabetes and 15.3% have prediabetes [2].
• Who is more likely to get it: people with overweight, obesity or a large waist, a family history of type 2 diabetes, and people of South Asian and several other ethnic backgrounds [1]; the NHS notes that risk rises from age 25 in people of South Asian background, compared with age 40 for white people [12].
• A long-term condition: WHO notes that diabetes can be treated and its consequences avoided or delayed with diet, physical activity, medicines and regular screening for complications [11].

What are the symptoms of type 2 diabetes in women and men?

Common symptoms are passing urine often, feeling very thirsty, feeling very hungry, blurred vision, tiredness, sores that do not heal and frequent infections such as urinary, skin or yeast infections, according to NIDDK [1].

• Often no symptoms: the NHS says not everyone with type 2 diabetes has symptoms, and they may develop gradually [12]; WHO notes they may take years to be noticed [11].
• Women and men: symptoms are largely the same; unintended weight loss, and itching around the vagina or penis or repeated thrush, can be signs, according to the NHS [12].
• Nerves and feet: over time, diabetes can damage nerves and cause tingling, pain or loss of feeling in the feet [13]; see our Neuropathy and Nerve Pain page.

Prediabetes HbA1c range and insulin resistance tests

Prediabetes means blood glucose is above the healthy range but below the diabetes range: according to the American Diabetes Association’s 2026 Standards of Care, an HbA1c of 5.7% to 6.4% or a fasting plasma glucose of 100 to 125 mg/dL indicates prediabetes, and an HbA1c of 6.5% or above or a fasting plasma glucose of 126 mg/dL or above indicates diabetes [14].

• Insulin resistance: cells in muscle, fat and liver respond poorly to insulin, so blood glucose begins to rise [1]. For insulin resistance with a larger waist, high triglycerides or high blood pressure, see our Metabolic Syndrome page.
• HOMA-IR: an estimate of insulin resistance calculated from fasting glucose and fasting insulin, first described in 1985 [15]; its authors note that it is best used to compare groups and to follow a person over time, and that results vary between laboratories [16]. There is no single agreed cut-off, and the ADA does not use fasting insulin or HOMA-IR to diagnose diabetes [14].
• C-peptide: shows how much insulin the pancreas is still producing, and helps distinguish types of diabetes [17].
• Yearly testing: the ADA advises testing people with prediabetes every year [14].
• Preventing progression: in the US Diabetes Prevention Program, lifestyle change lowered new cases of diabetes by 58% and metformin by 31% over about 3 years [18]; in the Indian Diabetes Prevention Programme, lifestyle change lowered them by 28.5% in Asian Indians with impaired glucose tolerance [19].

How is type 2 diabetes diagnosed?

Type 2 diabetes is diagnosed with blood tests: HbA1c (average blood glucose over about 3 months), fasting plasma glucose or an oral glucose tolerance test, according to NIDDK [20], with the diagnostic ranges set out by the ADA [14].

• HbA1c limits: NIDDK notes that HbA1c may be less accurate in pregnancy, some types of anaemia and some haemoglobin variants [20].
• Confirmation: the ADA usually requires two abnormal results, from the same sample or two samples, unless symptoms are clear [14].

How does Cure4Pain manage type 2 diabetes?

Cure4Pain manages type 2 diabetes as a long-term condition with a full blood panel including insulin tests, a low-carbohydrate home-cooked diet, strength training and daily walking, nutrient support and lifestyle counselling, with diabetes medicines managed by Dr Krushal Pabari under clinical guidance from Team Cure4Pain, in coordination with your existing consulting physician. Cure4Pain is an integrative and functional medicine clinic in Mumbai, with online consultations worldwide:

1. A full blood panel first: HbA1c, fasting glucose and insulin, and when needed C-peptide and HOMA-IR, with our standard panel of about 100 measures (see below).
2. Diet: low carbohydrate and low glycaemic, home-cooked, with no processed foods; jowar and millets in place of wheat; three meals a day within a daily eating window (intermittent fasting) where it is safe for you; raw foods and fruit limited (see the diet section).
3. Muscle and movement: the aim is to build lean muscle and reduce waist size rather than to reach a number on the scale, with resistance training, 5,000 to 7,000 steps a day, walking after meals and yoga. The DiRECT trial measured weight lost [4]; our clinic also tracks waist and muscle, which that trial did not use as targets.
4. Breathing and stress: Buteyko breathing as part of stress management (see the exercise section).
5. Nutrients: vitamin D and vitamin B12 guided by blood tests, and magnesium guided by diet, symptoms and history, because blood magnesium does not show how much the body holds [7]; doses are set for each person within official limits, with support for digestion and bile flow.
6. Medicines: Dr Krushal Pabari manages diabetes medicines and insulin under clinical guidance from Team Cure4Pain, in coordination with your existing consulting physician; medicines are reduced only gradually, never stopped abruptly, and only after blood markers stay improved; an endocrinologist is involved when needed.
7. Specialists from the start: for complex cases, we involve the relevant specialists from the first visit, so they monitor alongside our team and Dr Pabari.
8. Lifelong follow-up: reviews with blood tests every 3 months.

Clinic observation: in our clinic, people with type 2 diabetes who follow the plan often show a meaningful fall in HbA1c over about 6 to 9 months, varying from person to person, and medicines are reduced gradually only after blood results remain improved. This is an observation from our practice, not a trial result; many factors affect blood glucose, and further studies are needed.

What blood tests does Cure4Pain do for type 2 diabetes?

Before the first consultation, Cure4Pain tests blood glucose control, insulin resistance, nutrients and organ function as part of a wider panel of about 100 measures; this is our clinic protocol, not a guideline requirement:

• Glucose control: HbA1c, fasting glucose and fasting insulin; C-peptide and HOMA-IR when needed
• Lipid profile (cholesterol and triglycerides)
• Kidney function and liver function
• Vitamin D status with PTH, and vitamin B12
• Complete blood count, iron studies, thyroid tests, hsCRP
• ANA (antinuclear antibodies) by the IFA method, part of our standard panel for every patient

B12 matters because metformin can lower it [6], and kidney and cholesterol results matter because diabetes affects the kidneys and heart [11]. In India, the panel is available at a lower cost through our patient portal, with home collection across India. Outside India, the tests are done at a laboratory near you and reviewed with you in the consultation.

What is the best diet for type 2 diabetes? Low-carb, home-cooked, millets in place of wheat

There is no single ideal eating pattern for everyone with diabetes: the American Diabetes Association’s 2026 Standards advise individual meal plans, suggest considering lower carbohydrate intake for some adults, and advise minimising refined grains, sweets, sugary drinks and processed and ultra-processed foods [21]. Cure4Pain advises a low-carbohydrate, low-glycaemic, home-cooked diet, planned differently for vegetarians and non-vegetarians.

• Low carbohydrate: a 2021 BMJ meta-analysis of 23 trials (1,357 people) found that low-carbohydrate diets (under 130 g of carbohydrate a day or under 26% of energy) brought more people below an HbA1c of 6.5% at 6 months than control diets (57% vs 31%), with smaller effects when medicine use was also counted and less certainty at 12 months [22].
• No processed foods: in three large US cohorts, more ultra-processed food was linked with a higher risk of type 2 diabetes [23].
• Jowar and millets in place of wheat: a 2021 meta-analysis from ICRISAT and India’s National Institute of Nutrition found millets have a low glycaemic index and lowered fasting and after-meal blood glucose [24]. Replacing wheat with jowar and millets is our clinic practice; we found no study showing that wheat itself harms people with diabetes who do not have celiac disease.
• Fruit: as clinic practice, we limit fruit to once or twice a week. The research differs: the ADA includes whole fruit in healthy eating patterns for people with diabetes [21], and in three large US cohorts of people without diabetes, whole fruit (especially blueberries, grapes and apples) was linked with a lower risk of developing type 2 diabetes and fruit juice with a higher risk [25]. Fruit juice is best avoided.
• Raw foods, salads and raw vegetables: as clinic practice, we advise cooked rather than raw vegetables. Research has not tested raw against cooked vegetables in diabetes; a 2010 BMJ meta-analysis linked more green leafy vegetables with a 14% lower risk of type 2 diabetes [26], so we include cooked green vegetables daily.
• Three meals and intermittent fasting: a 2021 meta-analysis found intermittent fasting and continuous calorie restriction had similar effects on HbA1c, with slightly more weight loss with fasting [27]. In a trial of people taking glucose-lowering medicines, fasting doubled the rate of low blood glucose episodes even after medicines were reduced [28]; a 12-week trial of 46 people on insulin found no severe low blood glucose episodes when insulin was reduced under supervision [29]. Fasting with diabetes medicines is planned only with Dr Krushal Pabari, under clinical guidance from Team Cure4Pain.
• Ketogenic diets and certain medicines: the ADA discourages a ketogenic eating pattern in people taking SGLT2 inhibitor medicines, because of the risk of ketoacidosis [21].

How to lower HbA1c naturally: what the research shows

HbA1c falls with weight loss, changes in diet, regular activity and medicines: in the DiRECT trial, people who lost 15 kg or more had the highest rate of HbA1c below the diabetes range without medicines (86%) [4], and resistance training alone lowered HbA1c by about 0.4 percentage points in a 2022 meta-analysis [30].

• Timeline: HbA1c reflects about 3 months of blood glucose [20], so changes are judged over months, not days.
• Target: the ADA advises an HbA1c goal below 7% for many non-pregnant adults, and lower (for example below 6.5%) for some people when it can be reached safely [31].
• Weight and waist: in DiRECT, the chance of reaching an HbA1c below 6.5% without medicines rose with the amount of weight lost [4].
• Magnesium supplements: a 2022 meta-analysis of 18 trials found oral magnesium modestly lowered HbA1c and fasting glucose [32].
• Vitamin D supplements: a 2023 meta-analysis of 46 trials found small falls in HbA1c (0.2 percentage points), fasting glucose and HOMA-IR, mainly in people with low vitamin D, with differences between studies [33].

How much exercise helps type 2 diabetes? Strength training, steps and walking after meals

The American Diabetes Association advises most adults with type 2 diabetes to do at least 150 minutes of moderate to vigorous aerobic activity a week, spread over at least 3 days, plus 2 to 3 sessions of resistance exercise on non-consecutive days [21].

• Resistance training: a 2022 meta-analysis of 20 trials (1,172 people) found it lowered HbA1c by about 0.4 percentage points, with greater strength gains linked to larger falls [30].
• Steps: a 2025 meta-analysis in The Lancet Public Health found that more daily steps were linked with a lower risk of type 2 diabetes, and that about 7,000 steps a day was linked with meaningful health benefits [34].
• Walking after meals: in a 2022 meta-analysis of short trials, light walking breaks during long periods of sitting lowered blood glucose after meals more than standing breaks [35]; trials of walking straight after meals are small and short, and further studies are needed.
• Yoga: a 2023 meta-analysis of 16 studies found yoga, alongside diabetes medicines, lowered fasting glucose, HbA1c and insulin resistance [36].
• Buteyko breathing: as clinic practice, we use Buteyko breathing as part of holistic care for stress and metabolic health. We found no trial of it in diabetes; its trials are mainly in asthma, with moderate to very low certainty evidence (Cochrane review, 2020) [37], and a 2023 meta-analysis of 12 trials found breathwork in general linked with lower self-reported stress [38]. Further studies in diabetes are needed.

Vitamins and minerals for type 2 diabetes: magnesium, vitamin D and B12

No supplement replaces diabetes treatment; where vitamin D, magnesium or vitamin B12 run low, correcting them is part of our plan, within official limits.

• Vitamin D: the recommended intake is 600 IU a day for adults up to 70 and 800 IU over 70, and the upper limit is 4,000 IU a day, according to the US National Institutes of Health [39]; the trial evidence for diabetes prevention is mixed [9][10].
• Magnesium: most of the body’s magnesium is inside cells and bone, and blood magnesium does not show how much the body holds; the upper limit from supplements is 350 mg of elemental magnesium a day, and absorption varies by form, according to the US National Institutes of Health [7].
• Vitamin B12: the recommended intake is 2.4 mcg a day for adults; metformin can lower B12 levels, according to the US National Institutes of Health [3][6].
• Digestion and bile flow: as clinic practice, some people are given supplements that support digestive and bile acids; we found no trial of these in type 2 diabetes, and further studies are needed.

Diabetes medicines and insulin: how integrative care works alongside them

Many people with type 2 diabetes need medicines or insulin, and WHO notes that diabetes can be treated and its consequences avoided or delayed with diet, physical activity, medicines and regular screening [11]. At Cure4Pain, Dr Krushal Pabari manages diabetes medicines and insulin under clinical guidance from Team Cure4Pain, in coordination with your existing consulting physician, and involves an endocrinologist when needed.

• Gradual reduction only: medicines are reduced step by step, never stopped abruptly, and only after blood markers stay improved; never stop or change diabetes medicines without medical guidance.
• Low blood glucose: as diet and activity change, some medicines (especially insulin and some tablets) can cause low blood glucose; symptoms include shakiness, hunger and tiredness and can come on quickly, according to NIDDK [40].
• Ketoacidosis: the ADA advises people taking SGLT2 inhibitor medicines to learn the signs of ketoacidosis [21].

Type 2 diabetes remission: what it means and why monitoring continues

An expert group convened by the American Diabetes Association defines remission of type 2 diabetes as an HbA1c below 6.5% measured at least 3 months after stopping glucose-lowering medicines, and advises continued monitoring because blood glucose can rise again [41].

• What the trials show: in DiRECT, 46% of participants in the weight-management group met this target at 12 months and 36% at 2 years [4][42]; at 5 years, 13% of those who continued with support remained in remission [43].
• Remission is not the end of care: the ADA consensus advises continued monitoring during remission because blood glucose can rise again [41], and in DiRECT, lasting remission depended on keeping the weight off [42]. A person in remission therefore still needs lifelong care.
• At Cure4Pain: reaching an HbA1c below 6.5% is a milestone, not a reason to stop. We continue blood tests every 3 months, the diet and exercise plan and medical review for life. In our clinic, people who stop them often see blood glucose rise again; this is an observation, not a trial result, and further studies are needed.

What are the complications of type 2 diabetes? Feet, eyes, kidneys, heart and nerves

Over time, high blood glucose can damage the nerves, blood vessels, eyes, kidneys and heart; WHO reports that diabetes and diabetes-related kidney disease caused over 2 million deaths in 2021 [11], and NIDDK advises daily foot care because nerve damage can hide cuts and sores [13].

• Feet: check and wash your feet every day [13]. We do not use needling on the feet of people with diabetes or numb feet; please ask us before soaking your feet.
• Nerves: see our Neuropathy and Nerve Pain page.
• Shoulders: for shoulder pain and stiffness, see our Frozen Shoulder page.
• Yearly checks: the ADA advises checking kidney function (urine albumin-to-creatinine ratio and eGFR) at least once a year in everyone with type 2 diabetes [44], a full foot examination at least once a year, and regular eye examinations [45].
• Specialists: we involve eye, kidney and heart specialists from the start in complex cases.

Type 2 diabetes in pregnancy and before pregnancy

If you have diabetes and plan a pregnancy, NIDDK advises bringing blood glucose close to the target range before conception, because high blood glucose can harm the baby in the first weeks, and telling your doctor as soon as you are pregnant, as meal plans and medicines often change [46].

• At Cure4Pain: in pregnancy we use only standard supplement doses and do not use fasting, in coordination with your gynaecologist or existing consulting physician, because our clinic does not manage pregnancies.

When is type 2 diabetes an emergency?

Very low or very high blood glucose can be dangerous: the NHS advises calling emergency services if someone with diabetes becomes unconscious from low blood glucose, or has signs of diabetic ketoacidosis such as high ketone levels with feeling unwell [47][48]. Call 112 in India, 911 in the US or 999 in the UK. Seek urgent care for a foot cut or sore that becomes red, swollen or infected [13].

Does Cure4Pain work with my own doctor for type 2 diabetes?

Yes. We share our findings with your existing consulting physician, diabetologist or endocrinologist, and any change to diabetes medicines is made by Dr Krushal Pabari under clinical guidance from Team Cure4Pain, in coordination with your existing consulting physician.

What happens at a type 2 diabetes consultation?

After your blood panel, your first consultation (in Mumbai or online) covers your history, medicines, diet, activity and tests, and a written plan for diet, exercise, nutrients and medicines. Follow-up reviews with blood tests are planned every 3 months. Individual results vary.

Evidence: key studies

Who treats you

• Dr Krushal PabariMD, PGCP - Rheumatic & Musculoskeletal Diseases. Assistant Professor, Cooper Hospital; Guest Professor, CMP Homoeopathic Medical College.
• AT. Chintan Dalal, N.D.BNYS, R.AP. Functional nutrition and Coimbra Protocol practitioner.

Consultations look at the whole person: alongside the medical and nutritional plan, we bring a strong interest in behavioural science to counselling on stress, sleep and lasting lifestyle change.

How consultations work: Mumbai or online worldwide

Book through our patient portal. You can see us in person at our clinic in Malad West, Mumbai, or online from anywhere. Your first consultation reviews your history and tests; we then agree a plan together and set the monitoring schedule.

Related conditions and articles

• Hypothyroidism (Underactive Thyroid)Underactive thyroid; vitamin D, B12, iron, diet and thyroid care.
• Neuropathy & Nerve PainTingling, numbness and burning feet from diabetic and other neuropathy.
• Frozen ShoulderPainful, stiff shoulder, with blood sugar and thyroid checked first.
• Metabolic SyndromeInsulin resistance, belly fat, triglycerides and fatty liver; tests, diet, exercise and medicine review.

• Lifestyle and metabolic conditions
• Neuropathy and nerve pain

This page is for education and does not replace medical advice. Do not start, stop or change any medicine or supplement without medical guidance.

References

1. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), US National Institutes of Health. Symptoms & Causes of Diabetes. niddk.nih.gov/health-information/diabetes/overview/symptoms-causes

2. Anjana RM, et al. Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17). Lancet Diabetes Endocrinol 2023;11(7):474-489. doi:10.1016/S2213-8587(23)00119-5

3. Office of Dietary Supplements, US National Institutes of Health. Vitamin B12: Fact Sheet for Health Professionals. ods.od.nih.gov/factsheets/VitaminB12-HealthProfessional

4. Lean ME, et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet 2018;391(10120):541-551. doi:10.1016/S0140-6736(17)33102-1

5. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363(9403):157-63. doi:10.1016/S0140-6736(03)15268-3

6. Yang W, et al. Associations between metformin use and vitamin B(12) levels, anemia, and neuropathy in patients with diabetes: a meta-analysis. J Diabetes 2019;11(9):729-743. doi:10.1111/1753-0407.12900

7. Office of Dietary Supplements, US National Institutes of Health. Magnesium: Fact Sheet for Health Professionals. ods.od.nih.gov/factsheets/Magnesium-HealthProfessional

8. Zhao B, et al. Association of magnesium intake with type 2 diabetes and total stroke: an updated systematic review and meta-analysis. BMJ Open 2020;10(3):e032240. doi:10.1136/bmjopen-2019-032240

9. Pittas AG, et al. Vitamin D Supplementation and Prevention of Type 2 Diabetes. N Engl J Med 2019;381(6):520-530. doi:10.1056/NEJMoa1900906

10. Pittas AG, et al. Vitamin D and Risk for Type 2 Diabetes in People With Prediabetes : A Systematic Review and Meta-analysis of Individual Participant Data From 3 Randomized Clinical Trials. Ann Intern Med 2023;176(3):355-363. doi:10.7326/M22-3018

11. World Health Organization. Diabetes: fact sheet. who.int/news-room/fact-sheets/detail/diabetes

12. NHS. Symptoms of type 2 diabetes and how it’s diagnosed. nhs.uk/conditions/type-2-diabetes/symptoms

13. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), US National Institutes of Health. Diabetes & Foot Problems. niddk.nih.gov/health-information/diabetes/overview/preventing-problems/foot-problems

14. American Diabetes Association Professional Practice Committee for Diabetes. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2026. Diabetes Care 2026;49(Supplement_1):S27-S49. doi:10.2337/dc26-S002

15. Matthews DR, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28(7):412-9. doi:10.1007/BF00280883

16. Wallace TM, et al. Use and abuse of HOMA modeling. Diabetes Care 2004;27(6):1487-95. doi:10.2337/diacare.27.6.1487

17. Leighton E, et al. A Practical Review of C-Peptide Testing in Diabetes. Diabetes Ther 2017;8(3):475-487. doi:10.1007/s13300-017-0265-4

18. Knowler WC, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346(6):393-403. doi:10.1056/NEJMoa012512

19. Ramachandran A, et al. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 2006;49(2):289-97. doi:10.1007/s00125-005-0097-z

20. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), US National Institutes of Health. Diabetes Tests & Diagnosis. niddk.nih.gov/health-information/diabetes/overview/tests-diagnosis

21. American Diabetes Association Professional Practice Committee for Diabetes. 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2026. Diabetes Care 2026;49(Supplement_1):S89-S131. doi:10.2337/dc26-S005

22. Goldenberg JZ, et al. Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: systematic review and meta-analysis of published and unpublished randomized trial data. BMJ 2021;372:m4743. doi:10.1136/bmj.m4743

23. Chen Z, et al. Ultra-Processed Food Consumption and Risk of Type 2 Diabetes: Three Large Prospective U.S. Cohort Studies. Diabetes Care 2023;46(7):1335-1344. doi:10.2337/dc22-1993

24. Anitha S, et al. A Systematic Review and Meta-Analysis of the Potential of Millets for Managing and Reducing the Risk of Developing Diabetes Mellitus. Front Nutr 2021;8:687428. doi:10.3389/fnut.2021.687428

25. Muraki I, et al. Fruit consumption and risk of type 2 diabetes: results from three prospective longitudinal cohort studies. BMJ 2013;347:f5001. doi:10.1136/bmj.f5001

26. Carter P, et al. Fruit and vegetable intake and incidence of type 2 diabetes mellitus: systematic review and meta-analysis. BMJ 2010;341:c4229. doi:10.1136/bmj.c4229

27. Wang X, et al. Intermittent fasting versus continuous energy-restricted diet for patients with type 2 diabetes mellitus and metabolic syndrome for glycemic control: A systematic review and meta-analysis of randomized controlled trials. Diabetes Res Clin Pract 2021;179:109003. doi:10.1016/j.diabres.2021.109003

28. Corley BT, et al. Intermittent fasting in Type 2 diabetes mellitus and the risk of hypoglycaemia: a randomized controlled trial. Diabet Med 2018;35(5):588-594. doi:10.1111/dme.13595

29. Obermayer A, et al. Efficacy and Safety of Intermittent Fasting in People With Insulin-Treated Type 2 Diabetes (INTERFAST-2)-A Randomized Controlled Trial. Diabetes Care 2023;46(2):463-468. doi:10.2337/dc22-1622

30. Jansson AK, et al. Effect of resistance training on HbA1c in adults with type 2 diabetes mellitus and the moderating effect of changes in muscular strength: a systematic review and meta-analysis. BMJ Open Diabetes Res Care 2022;10(2). doi:10.1136/bmjdrc-2021-002595

31. American Diabetes Association Professional Practice Committee for Diabetes. 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026. Diabetes Care 2026;49(Supplement_1):S132-S149. doi:10.2337/dc26-S006

32. Asbaghi O, et al. The effects of oral magnesium supplementation on glycaemic control in patients with type 2 diabetes: a systematic review and dose-response meta-analysis of controlled clinical trials. Br J Nutr 2022;128(12):2363-2372. doi:10.1017/S0007114521005201

33. Farahmand MA, et al. What is the impact of vitamin D supplementation on glycemic control in people with type-2 diabetes: a systematic review and meta-analysis of randomized controlled trails. BMC Endocr Disord 2023;23(1):15. doi:10.1186/s12902-022-01209-x

34. Ding D, et al. Daily steps and health outcomes in adults: a systematic review and dose-response meta-analysis. Lancet Public Health 2025;10(8):e668-e681. doi:10.1016/S2468-2667(25)00164-1

35. Buffey AJ, et al. The Acute Effects of Interrupting Prolonged Sitting Time in Adults with Standing and Light-Intensity Walking on Biomarkers of Cardiometabolic Health in Adults: A Systematic Review and Meta-analysis. Sports Med 2022;52(8):1765-1787. doi:10.1007/s40279-022-01649-4

36. Dhali B, et al. Effect of Yoga and Walking on Glycemic Control for the Management of Type 2 Diabetes: A Systematic Review and Meta-analysis. J ASEAN Fed Endocr Soc 2023;38(2):113-122. doi:10.15605/jafes.038.02.20

37. Santino TA, et al. Breathing exercises for adults with asthma. Cochrane Database Syst Rev 2020;3(3):CD001277. doi:10.1002/14651858.CD001277.pub4

38. Fincham GW, et al. Effect of breathwork on stress and mental health: A meta-analysis of randomised-controlled trials. Sci Rep 2023;13(1):432. doi:10.1038/s41598-022-27247-y

39. Office of Dietary Supplements, US National Institutes of Health. Vitamin D: Fact Sheet for Health Professionals. ods.od.nih.gov/factsheets/VitaminD-HealthProfessional

40. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), US National Institutes of Health. Low Blood Glucose (Hypoglycemia). niddk.nih.gov/health-information/diabetes/overview/preventing-problems/low-blood-glucose-hypoglycemia

41. Riddle MC, et al. Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes. Diabetes Care 2021;44(10):2438-44. doi:10.2337/dci21-0034

42. Lean MEJ, et al. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial. Lancet Diabetes Endocrinol 2019;7(5):344-355. doi:10.1016/S2213-8587(19)30068-3

43. Lean ME, et al. 5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study. Lancet Diabetes Endocrinol 2024;12(4):233-246. doi:10.1016/S2213-8587(23)00385-6

44. American Diabetes Association Professional Practice Committee for Diabetes. 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2026. Diabetes Care 2026;49(Suppl 1):S246-S260. doi:10.2337/dc26-S011

45. American Diabetes Association Professional Practice Committee for Diabetes. 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes-2026. Diabetes Care 2026;49(Suppl 1):S261-S276. doi:10.2337/dc26-S012

46. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), US National Institutes of Health. Pregnancy if You Have Diabetes. niddk.nih.gov/health-information/diabetes/diabetes-pregnancy

47. NHS. Low blood sugar (hypoglycaemia). nhs.uk/conditions/low-blood-sugar-hypoglycaemia

48. NHS. Diabetic ketoacidosis. nhs.uk/conditions/diabetic-ketoacidosis

49. Hu EA, et al. White rice consumption and risk of type 2 diabetes: meta-analysis and systematic review. BMJ 2012;344:e1454. doi:10.1136/bmj.e1454